© Copyright 2025 American Medical Association. All rights reserved.
The CPT® Code 90476 refers to the Adenovirus vaccine, specifically type 4, which is administered orally. Vaccines, unlike immune globulins that offer short-term, passive immunity, provide active and long-lasting immunity. This is achieved by introducing altered forms of specific viruses or bacteria into the recipient's body, prompting the immune system to generate its own antibodies against these pathogens. Once vaccinated, the body retains a memory of how to produce these antibodies, enabling a quicker and more effective response upon subsequent exposure to the same antigen. Adenoviruses are known to cause a range of respiratory illnesses, including the common cold, croup, bronchitis, and pneumonia. Additionally, they can lead to other health issues such as conjunctivitis, cystitis, and gastroenteritis, which vary based on the specific serotype and the site of infection. The codes for adenovirus vaccines, including 90476 for type 4 and 90477 for type 7, are utilized solely to report the vaccine product administered.
© Copyright 2025 Coding Ahead. All rights reserved.
The Adenovirus vaccine, type 4, is indicated for the prevention of illnesses caused by adenoviruses, particularly respiratory infections. The following conditions are associated with the use of this vaccine:
The administration of the Adenovirus vaccine, type 4, involves the following procedural steps:
Following the administration of the Adenovirus vaccine, type 4, patients are typically advised to remain under observation for a brief period to ensure there are no immediate adverse reactions. It is important to inform patients about potential mild side effects, which may include gastrointestinal discomfort or mild fever. Patients should also be educated on the importance of completing the vaccination series, if applicable, and the need for follow-up appointments to monitor their health and ensure the vaccine's effectiveness. Additionally, healthcare providers should document the administration details in the patient's medical record, including the date, dosage, and any observed reactions.
| Short Descr | ADENOVIRUS VACCINE TYPE 4 | Medium Descr | ADENOVIRUS VACCINE TYPE 4 LIVE ORAL | Long Descr | Adenovirus vaccine, type 4, live, for oral use | Status Code | Excluded from Physician Fee Schedule by Regulation | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | ASC Payment Indicator | Packaged service/item; no separate payment made. | Type of Service (TOS) | 1 - Medical Care | Berenson-Eggers TOS (BETOS) | O1G - Immunizations/Vaccinations | MUE | 1 | CCS Clinical Classification | 228 - Prophylactic vaccinations and inoculations |
| 25 | Significant, separately identifiable evaluation and management service by the same physician or other qualified health care professional on the same day of the procedure or other service: it may be necessary to indicate that on the day a procedure or service identified by a cpt code was performed, the patient's condition required a significant, separately identifiable e/m service above and beyond the other service provided or beyond the usual preoperative and postoperative care associated with the procedure that was performed. a significant, separately identifiable e/m service is defined or substantiated by documentation that satisfies the relevant criteria for the respective e/m service to be reported (see evaluation and management services guidelines for instructions on determining level of e/m service). the e/m service may be prompted by the symptom or condition for which the procedure and/or service was provided. as such, different diagnoses are not required for reporting of the e/m services on the same date. this circumstance may be reported by adding modifier 25 to the appropriate level of e/m service. note: this modifier is not used to report an e/m service that resulted in a decision to perform surgery. see modifier 57 for significant, separately identifiable non-e/m services, see modifier 59. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Changed | Short description changed. |
| 1999-01-01 | Added | First appearance in code book in 1999. |
Get instant expert-level medical coding assistance.